Cadrenal Therapeutics, Inc. Common Stock (CVKD) Earnings
Cadrenal Therapeutics, Inc. Common Stock is expected to report next earnings on August 10, 2026 (in NaN days), with a consensus EPS estimate of $-1.55. CVKD has beaten EPS estimates in 2 of its last 8 reported quarters (average surprise -19.3% over the last four).
Next earnings
Aug 10, 2026in NaN days
EPS est $-1.55 · Revenue est —
Track record
Beat EPS in 2 of 8 quarters
Avg surprise -19.3% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 7, 2026 | $-1.51 | $-1.04 | +31.1% | — | — |
| Mar 31, 2026 | $-1.17 | $-1.41 | -20.5% | — | — |
| May 8, 2025 | $-1.64 | $-2.09 | -27.4% | — | — |
| Mar 13, 2025 | $-1.71 | $-2.74 | -60.2% | $2134 | — |
| Nov 7, 2024 | $-1.83 | $-2.18 | -19.1% | — | — |
| May 9, 2024 | $-1.05 | $-1.50 | -42.9% | — | — |
| Mar 11, 2024 | $-1.35 | $-0.75 | +44.4% | $2768 | — |
| Nov 9, 2023 | $-1.05 | $-1.05 | +0.0% | — | — |
| Aug 10, 2023 | — | $-1.35 | — | — | — |
| Jun 30, 2022 | — | $-0.04 | — | — | — |
| Mar 31, 2022 | — | $-0.02 | — | — | — |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.